315 related articles for article (PubMed ID: 27098626)
1. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
[TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
3. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus.
Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z
PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of elevated serum CXCL16 and severity of acute coronary syndromes in male elders].
Zhuge X; Wang LL; Sun N; Zhang Y
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3271-4. PubMed ID: 22333148
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease.
Sheikine Y; Bang CS; Nilsson L; Samnegård A; Hamsten A; Jonasson L; Eriksson P; Sirsjö A
Atherosclerosis; 2006 Oct; 188(2):462-6. PubMed ID: 16378611
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
[TBL] [Abstract][Full Text] [Related]
8. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M; Karaarslan O; Abali G; Batur MK
Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
[TBL] [Abstract][Full Text] [Related]
9. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
Mohan V; Deepa R; Velmurugan K; Premalatha G
Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
[TBL] [Abstract][Full Text] [Related]
10. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study.
Tan K; Lu S; Chen Y; Song X; Wu X; Jin Z; Yuan F; Zhou Y; Li H; Yang T; Zhou Y; Li Z; Chen F; Zhang S; Guo L; Wang W; Zhao Q; Huo Y; Yang X; Liu J; Chen B; Yan H; Li H; Ke Y; Chen K; Shi D
Tohoku J Exp Med; 2011 Apr; 223(4):277-83. PubMed ID: 21467783
[TBL] [Abstract][Full Text] [Related]
12. Elevated high sensitivity C-reactive protein and uric acid levels in coronary artery ectasia.
Demir Ş; Karakoyun G; Kanadasi M
Acta Biochim Pol; 2014; 61(4):687-91. PubMed ID: 25285332
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
14. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
[TBL] [Abstract][Full Text] [Related]
15. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
[TBL] [Abstract][Full Text] [Related]
16. Serum S100A12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
Zhao P; Wu M; Yu H; Huang Y; Wang Y; Wang W; Yin W
J Investig Med; 2013 Jun; 61(5):861-6. PubMed ID: 23609464
[TBL] [Abstract][Full Text] [Related]
17. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics.
Wu W; Li Q; Xia J; Wang M; Sun Z; Miao J; Zheng Z
Hum Immunol; 2013 Mar; 74(3):379-82. PubMed ID: 23220502
[TBL] [Abstract][Full Text] [Related]
18. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
[TBL] [Abstract][Full Text] [Related]
19. Increase of Serum CXCL16 Level Correlates Well to Microembolic Signals in Acute Stroke Patients with Carotid Artery Stenosis.
Ma A; Yang S; Wang Y; Wang X; Pan X
Clin Chim Acta; 2016 Sep; 460():67-71. PubMed ID: 27355560
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
